Bill

Bill > HR1092


US HR1092

US HR1092
BENEFIT Act of 2023 Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023


summary

Introduced
02/17/2023
In Committee
02/24/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

A BILL To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.

AI Summary

This bill, the Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 (BENEFIT Act of 2023), aims to strengthen the use of patient-experience data within the risk-benefit assessment framework for the approval of new drugs. Specifically, the bill amends the Federal Food, Drug, and Cosmetic Act to require the consideration of patient-experience data as part of the risk-benefit assessment process for new drug approvals. Additionally, the bill mandates that the FDA provide a description of how such patient-experience data was considered in the risk-benefit assessment when approving new drugs.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (32)

Last Action

Referred to the Subcommittee on Health. (on 02/24/2023)

Bill Topics

Health
  • ‐ Regulation of Drug Industry and Pharmacies
  • ‐ Research and Development

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.congress.gov/bill/118th-congress/house-bill/1092/all-info 02/18/2023
BillText https://www.congress.gov/118/bills/hr1092/BILLS-118hr1092ih.pdf 03/14/2023
Loading...